Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Innate inflammatory response and immunopharmacologic activity of micafungin, caspofungin, and voriconazole against wild-type and FKS mutant Candida glabrata isolates.

Antimicrobial agents and chemotherapy - 1 Sept 2015

Beyda Nicholas D, Liao Guangling, Endres Bradley T, Lewis Russell E, Garey Kevin W

Abstract excerpt

The direct or indirect interactions that antifungals have with the host immune response may play a significant role in defining their activity in vivo. However, the impact that acquired antifungal resistance has on the immunopharmacologic activity of antifungals is not well described. We assessed the immunopharmacologic activity of caspofungin, micafungin, and voriconazole among isolates of Candida glabrata with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antifungal Agents
Share to beta-Glucans

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Candida glabrata

Share to Candidemia

Share to Caspofungin

Share to Echinocandins

Share to Lipopeptides

Share to Voriconazole

Source

Open in PubMed Open full text

Identifiers

PMID: 26100700
DOI: 10.1128/AAC.00624-15
PMCID: PMC4538525

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Innate inflammatory response and immunopharmacologic activity of micafungin, caspofungin, and voriconazole against wild-type and FKS mutant Candida glabrata isolates.PMID 26100700Read ↗

Multidimensional assessment of in-host fitness costs of echinocandin resistance in the opportunistic fungal pathogen Candida glabrata reveals the niche-specific requirement for FKS1 and FKS2 during infection and gut colonization.Semantic proximity Read ↗

FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia.Semantic proximity Read ↗

Role of FKS Mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance.Semantic proximity Read ↗

Resistance to echinocandins comes at a cost: the impact of FKS1 hotspot mutations on Candida albicans fitness and virulence.Semantic proximity Read ↗

FKS mutations and elevated echinocandin MIC values among Candida glabrata isolates from U.S. population-based surveillance.Semantic proximity Read ↗

In vitro antifungal susceptibility of Candida glabrata to caspofungin and the presence of FKS mutations correlate with treatment response in an immunocompromised murine model of invasive infection.Semantic proximity Read ↗

Novel FKS mutations associated with echinocandin resistance in Candida species.Semantic proximity Read ↗

Clinical perspectives on echinocandin resistance among Candida species.Semantic proximity Read ↗

Echinocandin Resistance in Candida.Semantic proximity Read ↗

Caspofungin MICs correlate with treatment outcomes among patients with Candida glabrata invasive candidiasis and prior echinocandin exposure.Semantic proximity Read ↗

Evolutionary dynamics in gut-colonizing Candida glabrata during caspofungin therapy: Emergence of clinically important mutations in sphingolipid biosynthesis.Semantic proximity Read ↗

Hotspot gene conversion between FKS1 and FKS2 in echinocandin resistant Candida glabrata serial isolatesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.